• ▶ Aicardi-Gouti
Chilblains as a Diagnostic Sign of Aicardi-Gouti è res Syndrome
nucleases [5, 6, 24] . In a recent study of genotypephenotype correlations, neonatal onset or a more severe abnormal neurology were more frequent among patients with AGS1 / TREX1 related disease, while patients with AGS2 / RNASEH2B mutations tended to be less severely aff ected with a signifi cantly later age at presentation [20, 22] . AGS5 / SAMHD1 mutations are present in 10 % of AGS patients and the associated phenotype is currently less well characterized but possibly associated with a broad range of infl ammatory phenotypes [9] . AGS-associated chilblains were fi rst described by Tolmie et al. in 1995 [28] . Although this was almost 10 years after the original description of AGS, the current literature suggests that approximately 40 % of patients experience such chilblain skin lesions [8, 10, 13, 14, 19, 25, 26] . Chilblains can be seen in association with mutations in any of the AGS1 -5 genes and can be considered the most distinctive extra-neurological manifestation of the disease [5, 6, 24] . This sign is also of note since it highlights the pathophysiological overlap of AGS with some aspects of systemic lupus erythematosus (SLE), as evidenced by the recent identifi cation of TREX1 / AGS1 mutations in AGS, SLE [23] and familial chilblain lupus [17] .
Introduction ▼
In its classical form, Aicardi-Gouti è res syndrome (AGS: MIM 225750) can be usefully considered as a clinical and biochemical mimic of the sequelae of congenital infection. Most typically, aff ected children demonstrate severe developmental delay associated with the presence of intracranial calcifi cation, white matter disease and raised levels of white cells and interferon alpha (IFN-α ) in the cerebrospinal fl uid (CSF) [1, 16] . However, with the identifi cation of the genes mutated in AGS, it has become clear that the criteria previously considered mandatory for a clinical diagnosis of AGS no longer necessarily apply [22, 27] . Thus, neurological dysfunction is not invariably progressive, intelligence and head circumference can be normal [15, 18] , and brain atrophy is not inevitable. In addition, CSF lymphocytosis and elevated titres of CSF IFN-α are not always present in molecularly proven cases [15, 22] . In contrast, further delineation of the AGS phenotype has emphasized the importance of non-neurological features such as chilblains and glaucoma in the clinical recognition of the disease [4, 28] . The genes mutated in AGS have been recently defi ned to encode TREX1 , the RNASEH2 complex and SAMHD1, which may all function as cellular 
Case Reports ▼ Patient 1
This male was the third child born to a 27-year-old mother and 42-year-old father. The parents are maternal and paternal fi rst cousins (double consanguineous). The fi rst and fourth pregnancy resulted in 2 daughters, one died immediately after birth of undefi ned cause, the other succumbed 15 days after birth with respiratory distress. A postmortem examination was not performed for either deceased sibling. There was no family history of chilblains or autoimmune disease. TORCH screening (Toxoplasmosis, Rubella, CMV, Herpes simplex), before pregnancy and in the 12 th and 34 th week of gestation, together with serial ultrasound examination throughout the pregnancy, were normal. The child was born at 42 weeks by spontaneous vaginal delivery after an uncomplicated pregnancy. Neonatal anthropometric parameters were not recorded but mentioned to be normal. There were no neonatal problems. He was breast-fed and gained weight satisfactorily. He was healthy until the age 6 months when the parents noticed increasing size of the left eye and clouding of the cornea. Ophthalmological examination under anaesthesia showed a normal corneal diameter but increased intraocular pressure in the left eye diagnosed as open angle glaucoma. Intraocular pressure was controlled with a topical beta-blocker and carbonic anhydrase inhibitor. At that time, serology for TORCH infections and antibodies to adenovirus and enterovirus were negative. He was assessed at age 13 months because his parents noticed episodes of fever recurring at a frequency of approximately once a week and lasting 3 days at a time. The fever was not accompanied by encephalopathy, irritability or disturbed sleep pattern. The child was hospitalized for diagnostic investigations (including blood count, urine analysis, CRP, ESR, immunoglobulin levels and complement) all of which were unremarkable. He underwent routine vaccination without complications. At this time, his developmental milestones refl ected a mild delay, only fully supporting his head at the age of 9 months, sitting supported at age 12 months, standing with support at 18 months, saying meaningful words at age 17 months, and speaking in sentences at 2 ½ years. At the age of 2 years it was noticed that he was unable to stand with support as he had previously. Cerebral computed tomography (CT) performed at this time revealed bilateral tiny calcifi cations in the basal ganglia ( • ▶ Fig. 1 ). A subsequent CT performed at the age of 5 ½ years demonstrated increased density of the observed basal ganglia calcifi cation ( • ▶ Fig. 1 ).
At the age of 3 years he developed a persistent skin rash involving the hands, feet and helices of the ear. These lesions were signifi cantly exacerbated by cold. There was no history of photosensitivity, weight loss, immune defi ciency, or malignancy.
In the active period, the aff ected areas were erythematous and swollen. Some pedal lesions ulcerated to result in destruction of the distal joints of the toes. Healing produced well circumscribed scaly erythematous plaques and areas of atrophic skin ( • ▶ Fig. 2 ).
This process lasted for at least 3 months. Within 3 years his condition progressed to aff ect the upper limbs and produce necrosis at the toes. In view of the skin manifestations and a high ESR (92 and 125 in fi rst and second hour, respectively), a diagnosis of systemic lupus was considered. However, this diagnosis was subsequently discounted on the basis of normality of antinuclear antibodies (ANA) titres, lupus anticoagulant, and protein C activity. Further, antiphospholipid antibodies, anticardiolipin IgG and IgM, alpha-1 antitrypsin, cryofi brinogen, cryoglobulins, complement levels (C4 and C8), and coagulation indices were also negative. Biopsy performed at the edge of a necrotic skin lesion showed no hyperkeratosis, and normal epidermis and dermis ( • ▶ Fig. 3 ).
However, there were thick-walled vessels with intra-vascular thrombosis, necrosis of fat cells (marked by a loss of nuclei), and a network of hyaline deposits between the fat cells. Direct immunofl uorescence of IgM was negative. We fi rst examined the patient at the age of 5 ½ years. His weight, length and head circumference were 13.5 kg ( − 2.5 SD), 89.5 cm ( − 4 SD) and 50 cm ( − 1SD), respectively. We observed a large left cornea, facial erythema, and multiple erythematous purple chilblain lesions of the upper and lower limbs and on the sides of both feet. Areas of necrosis with crust formation were also seen on these plaques. He exhibited uncoordinated, dystonic arm movements. Tone was increased and deep tendon refl exes were hyperactive in the upper and lower limbs. Ophthalmoscopy showed tigroid fundi with relatively poor pigmentation of the macula and a small macular refl ex. The optic discs were pale and cupped. An EEG recording demonstrated a background of alpha and some theta waves. Nerve conduction studies revealed evidence of a peripheral neuropathy mainly aff ecting the sensory nerves. A cerebrospinal fl uid examination for IFN-α was normal (2 IU / mL) (white cell count not recorded).
Further assessment at age 7 years revealed an estimated intelligence quotient of 60, unchanged features of spasticity and a head circumference continuing along the 50 th centile. He had never experienced seizures. Review of his results revealed an intermittent mild elevation of liver enzymes (in the face of negative investigations for infectious causes of hepatitis), and abdominal ultrasound at this time showed mild hepatosplenomegaly. Chromosomal examination from peripheral blood lymphocytes was 46,XY and mutation analysis of the AGS1 -4 genes was normal. PCR amplifi cation of exons 1 -13 of SAMHD1 failed repeatedly using DNA from this child, in spite of good amplifi cation of exons 14, 15 and 16 using the same DNA, and amplifi cation of parental and control DNA for all exons of SAMHD1 . These fi nd-ings were consistent with a homozygous deletion of exons 1 -13 in the aff ected child. This fi nding was confi rmed by sequencing across the deletion using 5 ′ and 3 ′ primers situated upstream of exon 1 and within intron 13 -14 respectively (see • ▶ Fig. 7 ). He died at the age of 9 years because of gastroenteritis.
Patient 2
Patient 2 is the only daughter of healthy, consanguineous Egyptian parents. Family history was negative for a history of chilblains, mental retardation or epilepsy. This pregnancy was preceded by a single intrauterine foetal death at 36 weeks gestation. She was delivered vaginally weighing 1 500 g ( − 3.7 SD) at 38 weeks gestation. Her birth length and head circumference were not recorded. There were no immediate perinatal problems. However, irritability and frequent crying were reported from soon after birth. At age 6 months she experienced generalized tonic-clonic seizures characterized by up to 5 seizures per day showing some response to sodium valproate and lamotrigine. Cranial CT performed at this age showed brain atrophy and periventricular and basal ganglia calcifi cation and scattered calcifi cation in the white matter ( • ▶ Fig. 4 ). At the age of 18 months the patient developed skin lesions that started on the toes and to lesser extent on the hands and the ears. These skin lesions were exacerbated by exposure to cold. The aff ected areas were erythematous and swollen. These lesions healed to leave circumscribed scaly erythematous plaques ( • ▶ Fig. 5 ). This process lasted for at least 3 months. The aff ected areas never return to normal. At age 24 months she was unable to control her head, language was absent and she smiled only occasionally. She was non-dysmorphic. On clinical examination at the age of 2 ½ years her weight, length and head circumference were 7 kg ( − 3.9 SD), 70 cm ( − 4.8 SD) and 39.5 cm ( − 6 SD), respectively. The TORCH screen was negative. Between 3 and 20 months of life she experienced episodes of sterile pyrexia, approximately once a week, lasting 2 days at a time. Over the fi rst 2 years of life she devel- oped a spastic dystonic tetraparesis with no acquisition of motor skills.
A biopsy performed at the edge of a necrotic skin lesion revealed almost identical changes to those observed in patient 1 ( • ▶ Fig. 6 ). Alcian blue stain did not show any increase of mucin.
Further investigations including complement assays, autoantibody profi le, calcium, phosphate, blood lactate and pyruvate, and parathyroid hormone were all normal. Abdominal ultrasound showed hepatosplenomegaly and liver enzymes on diff erent occasions were elevated (with negative results for infectious causes of hepatitis). Analysis of the CSF at age 24 months showed markedly raised level of interferon-alpha (37 IU / L). An EEG recording demonstrated multiple epileptogenic foci. Fundus examination was reported to show bilateral abnormal retinal pigmentation with optic atrophy. Chromosomal examination of peripheral blood lymphocytes showed a normal 46,XX karyotype. Mutation analysis recorded a homozygous c.393_408 dup16 (p.Glu 137fs) mutation in the AGS1 gene TREX1 .
Discussion ▼
The 2 children described here demonstrate a clinical picture consistent with AGS. Patient 2 showed an early onset encephalopathy, microcephaly, seizures, hepatosplenomegaly and high IFN-α in the CSF. These manifestations fi t well with the neonatal form of AGS as proven by the fi nding of a homozygous mutation in TREX1 . Patient 1 shows glaucoma, chilblains, intermittent sterile pyrexias and hepatomegaly, all well recognized features of AGS [4, 14, 22] . Additionally, he demonstrates typical intracranial calcifi cation. Mild developmental delay is fully compatible with the diagnosis of AGS, and normal IFN-α titre at age 5 years is unsurprising. His diagnosis was confi rmed by defi ning a homozygous deletion of exons 1 -13 of SAMHD1 . The similarity of the severe skin lesions to those described in chilblain lupus, and the recognition that a disturbance of IFN-α metabolism is likely central to the pathogenesis of both AGS and juvenile systemic lupus erythematosus (JSLE), led us to consider JSLE in the diff erential diagnosis of our 2 patients. However, each disorder has its distinct diagnostic criteria. The absence of appropriate immunological markers and lack of increased mucin on Alcian blue stain (a diagnostic sign that is considered to apply to all stages and forms of cutaneous LE) in the 2 patients described here, provided evidence against this diagnosis [2] . It is of note that the histopathology of chilblains in AGS patients in previous reports has not drawn a uniform picture ( • ▶ Our patients demonstrated thrombosis of the superfi cial dermal vessels and extensive fat necrosis with hyalinization but negative immunofl uorescence and ANA. In view of the proposed immunological basis of AGS, discordance for immunological markers, Alcain blue and the deposition of IgM deposits along the basement membrane is of particular note. As has been similarly reported in SLE [29] , it is possible that there is a correlation between the fi ndings of positive immunofl uorescence with the detection of antinuclear antibodies in the serum. More generally, the diff erence in appearance of the histopathology of AGS-related skin lesions could relate to the stage and severity of the disease [2] . The typical histopathological changes seen in chilblain lupus include dermal edema, keratinocyte necrosis, and a deep dermal lymphocytic infi ltrate particularly prominent around vessels and eccrine glands [11, 12] . Thrombosis of the superfi cial dermal vessels observed in our 2 patients has been similarly reported in some cases with chilblain lupus [7, 12] . The observation of thrombi formation with associated degenerative changes (hyalinization) adds weight to the suggestion that AGS may be a microangiopathy [3, 21] . However, it is not clear if the underlying primary change is a primary vasculopathy or an infl ammatory process that secondarily induces moderate vascular changes. In conclusion, the 2 patients described here illustrate the importance of chilblain lesions as a diagnostic sign in AGS, and highlight the potential interest of better defi ning the histopathology of AGS-related skin disease. 
